Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 27532
Evènement :Precision CRISPR: Drug Discovery and Gene Therapy London 2018

Dates :Lundi 22 Octobre 2018 - Mercredi 24 Octobre 2018

Lieu :The Hilton London Olympia
380 Kensington High St, Kensington
W14 8N London, Royaume-Uni

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

Precision CRISPR: Drug Development and Gene Therapy Congress returns for the 3rd time, just in time to face the building excitement in getting CRISPR gene therapy into the clinic. Take a look at the conference program and engage with this community today: https://bit.ly/2zdRx77
 
Through a dynamic program of focused sessions, interactive discussions and networking opportunities, you will leave this meeting with a deep understanding of:
- the challenges in delivery and reducing off-target effects in ex vivo and in vivo gene therapies
- how the likes of GSK, Novartis, AstraZeneca and more, work towards improving the efficacy of functional screening and drug discovery
- the most recent gene editing techniques and Cas variants poised to make precise gene editing all that more precise
 
Preview Agenda Highlights:
Discover how to detect in vitro and ex vivo cellular indel profiles and dynamics induced by different CRISPR/Cas9 delivery formats with insights from Eric Paul Bennett, University of Copenhagen
Explore how Jacob Corn, ETH Zurich is forwarding gene repair in Human Hematopoietic Stem Cells and progressing towards translation of gene editing therapies for sickle cell disease
Find out how Barry Rosen, VP, AstraZeneca is utilising precise genome engineering to empower drug discovery 
 
To find out more, get your event program here: https://bit.ly/2zdRx77
URLs:
Time: 08:00 to 17:00
Speakers: Jacob Corn, Professor, UZH, Fredrik Wermeling, Assistant Professor, Karolinska Institute , Eric Paul Bennett, Associate Professor, University of Copenhagen, Andrew Bassett, Head of Research (Cellular Operations), Wellcome Trust Sanger Institute, Quin Wills, Department Head, Cellular and Systems Genomics, Novo Nordisk Research Centre, Barry Rosen, VP and Senior Principal Scientist, AstraZeneca , Lorena Benedetti, Research Associate, KCL and The Francis Crick Institute

Lieu

Plan et itinéraire
Adresse de la conférence :
The Hilton London Olympia
380 Kensington High St, Kensington
W14 8N London
Royaume-Uni
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

Precision CRISPR: Drug Discovery and Gene Therapy London 2018 Médecine générale
--
Tout public
-- -- --
English

Divers

Pour plus d'informations sur Precision CRISPR: Drug Discovery and Gene Therapy London 2018, veuillez contacter HansonWadeLtd

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement